Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05405309
Title RP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic Leukemia (CORONADO CLL)
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors University of Utah
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST